1. Home
  2. ARBEW vs REVBW Comparison

ARBEW vs REVBW Comparison

Compare ARBEW & REVBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARBEW
  • REVBW
  • Stock Information
  • Founded
  • ARBEW 2015
  • REVBW N/A
  • Country
  • ARBEW Israel
  • REVBW United States
  • Employees
  • ARBEW N/A
  • REVBW 9
  • Industry
  • ARBEW EDP Services
  • REVBW Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARBEW Technology
  • REVBW Health Care
  • Exchange
  • ARBEW Nasdaq
  • REVBW Nasdaq
  • Market Cap
  • ARBEW N/A
  • REVBW N/A
  • IPO Year
  • ARBEW N/A
  • REVBW 2020
  • Fundamental
  • Price
  • ARBEW $0.22
  • REVBW $0.02
  • Analyst Decision
  • ARBEW
  • REVBW
  • Analyst Count
  • ARBEW 0
  • REVBW 0
  • Target Price
  • ARBEW N/A
  • REVBW N/A
  • AVG Volume (30 Days)
  • ARBEW 35.7K
  • REVBW N/A
  • Earning Date
  • ARBEW 03-05-2025
  • REVBW N/A
  • Dividend Yield
  • ARBEW N/A
  • REVBW N/A
  • EPS Growth
  • ARBEW N/A
  • REVBW N/A
  • EPS
  • ARBEW N/A
  • REVBW N/A
  • Revenue
  • ARBEW $768,000.00
  • REVBW N/A
  • Revenue This Year
  • ARBEW N/A
  • REVBW N/A
  • Revenue Next Year
  • ARBEW N/A
  • REVBW N/A
  • P/E Ratio
  • ARBEW N/A
  • REVBW N/A
  • Revenue Growth
  • ARBEW N/A
  • REVBW N/A
  • 52 Week Low
  • ARBEW $0.16
  • REVBW N/A
  • 52 Week High
  • ARBEW $0.23
  • REVBW N/A
  • Technical
  • Relative Strength Index (RSI)
  • ARBEW N/A
  • REVBW N/A
  • Support Level
  • ARBEW N/A
  • REVBW N/A
  • Resistance Level
  • ARBEW N/A
  • REVBW N/A
  • Average True Range (ATR)
  • ARBEW 0.00
  • REVBW 0.00
  • MACD
  • ARBEW 0.00
  • REVBW 0.00
  • Stochastic Oscillator
  • ARBEW 0.00
  • REVBW 0.00

About ARBEW Arbe Robotics Ltd. Warrant

Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, USA, and others.

About REVBW Revelation Biosciences Inc. Warrant

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: